Introduction
The active pharmaceutical ingredient in diphtheria vaccines is diphtheria toxoid which is prepared by treatment of diphtheria toxin with formaldehyde and glycine. This detoxification process results in covalent modifications while maintaining immunogenicity. Detoxification is critical for both the safety and effectiveness of the vaccine. We studied these modifications by a combination of mass spectrometric techniques.
Methods
The workflow is shown in figure 1.
• Reaction with formaldehyde and NaCNBH 3 to prevent the formation of inter-and intramolecular crosslinks [1] . • Reaction with formaldehyde (CH 2 O or CD 2 O) and glycine. • Analysis of digests by nanoscale LC/MS [2] (LTQ Orbitrap XL, Bruker HCT Ultra). • Allocation of mass spectral doublets by MsXelerator ® software (MsMetrix, The Netherlands). • Targeted CID, multistage CID and ETD fragmentation for sequence information.
Results
PROBLEM: Direct identification of chemical adducts in diphtheria toxoid by proteolytic digestion and LC-MS/MS analysis is complicated because most peptides are not modified. SOLUTION: The use of formaldehyde (CH 2 O) and deuteriumlabeled formaldehyde (CD 2 O) allowed the unambiguous recognition of the modified peptides by their unique isotope pattern ( Figure 2 ). In total, 126 modified peptides with one to eight incorporated formaldehyde molecules were identified by their unique mass spectral doublet. From a previous study with synthetic peptides [3] we elucidated the structures of formaldehyde-glycine adducts. Arginine residues react with two formaldehyde molecules and one glycine molecule resulting in a net addition of C 4 H 5 NO 2 (M=99.032 Da). Tyrosine residues and, to a lesser extent asparagine, glutamine, histidine and tryptophan, residues react with one formaldehyde molecule and one glycine molecule to an adduct with a net addition of C 3 H 5 NO 2 (M=87.032Da).
High mass accuracy measurements (<5ppm) enabled us to predict a large number of peptides with chemical adducts, based on MS1 data. Peptides were fragmented by (multistage) CID and ETD to localize the sites of modifications.
PROBLEM: In some cases neutral losses prevent assignment of modifications (figure 4b). The spectrum shows a predominant neutral losses of 43.5 at z=2. Based on accurate mass measurements the suggested peptide is GDGASRVVL, but the location of the adduct could not be assigned. SOLUTION: Fragments were selected for multistage fragmentation. Neutral losses 37.5 (z=2) and 25 (z=3) Da were triggered for the 75 Da (C 3 H 5 NO 2 ) fragment loss, and 43.5/44.5 (z=2) 29/29.7 (z=3) were triggered for the 87/89 Da (C 4 H 5 NO 2 ) fragment loss. Joost P. Uittenbogaard, Alex de Haan, Ad P.J.M. de Jong, Hugo D. Meiring, Geert P.M. Mommen, Gideon F.A. Kersten, Bernard Metz
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PROBLEM: The spectrum in figure 6 shows a pattern of neutral losses of 29 Da. Based on accurate mass measurements the suggested peptide is IKRFGDGASRVVL, but adducts could not be assigned to specific residues. Selecting one of the neutral loss fragments for multistage activation lead to disappearance of that specific neutral loss peak, but no backbone fragmentation occurred. SOLUTION: To assign formaldehyde-glycine adducts ETD fragmentation was performed with the same nanoscale LC system but now coupled to a Bruker HCT Ultra mass spectrometer with an ETD source.
ETD fragmentation enabled the localization of the modification sites. Formaldehyde-glycine adducts were detected on tyrosine, arginine and to a lesser extent, on asparagine residues. We identified 58 of the 126 modified peptides and assigned the location of the formaldehyde-glycine adducts. For 51 modified peptides the sequence could be predicted by the accurate masses, sequences of 17 peptides are not yet identified.
Conclusion
By combining accurate mass, the number of formaldehydeglycine modifications and CID, multistage and ETD fragmentation spectra, 85% of the mass spectral doublets were identified. Modified peptides derived from the catalytic domain and the receptor domain were found. Probably modifications in these functional sites contribute to the detoxification of the diphtheria toxin. 
